Literature DB >> 34939171

Vascular Cognitive Impairment (VCI).

Tatjana Rundek1, Magdalena Tolea2, Taylor Ariko2, Eric A Fagerli2, Christian J Camargo2.   

Abstract

Vascular cognitive impairment (VCI) is predominately caused by vascular risk factors and cerebrovascular disease. VCI includes a broad spectrum of cognitive disorders, from mild cognitive impairment to vascular dementia caused by ischemic or hemorrhagic stroke, and vascular factors alone or in a combination with neurodegeneration including Alzheimer's disease (AD) and AD-related dementia. VCI accounts for at least 20-40% of all dementia diagnosis. Growing evidence indicates that cerebrovascular pathology is the most important contributor to dementia, with additive or synergistic interactions with neurodegenerative pathology. The most common underlying mechanism of VCI is chronic age-related dysregulation of CBF, although other factors such as inflammation and cardiovascular dysfunction play a role. Vascular risk factors are prevalent in VCI and if measured in midlife they predict cognitive impairment and dementia in later life. Particularly, hypertension, high cholesterol, diabetes, and smoking at midlife are each associated with a 20 to 40% increased risk of dementia. Control of these risk factors including multimodality strategies with an inclusion of lifestyle modification is the most promising strategy for treatment and prevention of VCI. In this review, we present recent developments in age-related VCI, its mechanisms, diagnostic criteria, neuroimaging correlates, vascular risk determinants, and current intervention strategies for prevention and treatment of VCI. We have also summarized the most recent and relevant literature in the field of VCI.
© 2021. The American Society for Experimental NeuroTherapeutics, Inc.

Entities:  

Keywords:  Biomarkers; Cognition; Neuroimaging; Small vessel disease; Vascular cognitive impairment; Vascular risk factors

Mesh:

Year:  2021        PMID: 34939171      PMCID: PMC9130444          DOI: 10.1007/s13311-021-01170-y

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   6.088


  286 in total

1.  Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials.

Authors:  David S Wald; Anuradhani Kasturiratne; Mark Simmonds
Journal:  Am J Med       Date:  2010-06       Impact factor: 4.965

2.  Effect of smoking and time on cognitive function in the elderly without dementia.

Authors:  Christiane Reitz; Jose Luchsinger; Ming-Xin Tang; Richard Mayeux
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

3.  Associations of vegetable and fruit consumption with age-related cognitive change.

Authors:  M C Morris; D A Evans; C C Tangney; J L Bienias; R S Wilson
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

Review 4.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

Review 5.  Atrial Fibrillation and Cognitive Impairment: New Insights and Future Directions.

Authors:  Alireza Sepehri Shamloo; Nikolas Dagres; Andreas Müssigbrodt; Annina Stauber; Simon Kircher; Sergio Richter; Boris Dinov; Livio Bertagnolli; Daniela Husser-Bollmann; Andreas Bollmann; Gerhard Hindricks; Arash Arya
Journal:  Heart Lung Circ       Date:  2019-06-21       Impact factor: 2.975

6.  Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Takeshi Kawarabayashi; Mikio Shoji; Linda H Younkin; Lin Wen-Lang; Dennis W Dickson; Tetsuro Murakami; Etsuro Matsubara; Koji Abe; Karen Hsiao Ashe; Steven G Younkin
Journal:  J Neurosci       Date:  2004-04-14       Impact factor: 6.167

Review 7.  Lipids of nervous tissue: composition and metabolism.

Authors:  P S Sastry
Journal:  Prog Lipid Res       Date:  1985       Impact factor: 16.195

Review 8.  Cognitive impairment in patients with cerebrovascular disease: A white paper from the links between stroke ESO Dementia Committee.

Authors:  Ana Verdelho; Joanna Wardlaw; Aleksandra Pavlovic; Leonardo Pantoni; Olivier Godefroy; Marco Duering; Andreas Charidimou; Hugues Chabriat; Geert Jan Biessels
Journal:  Eur Stroke J       Date:  2021-02-28

9.  Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample.

Authors:  Chris Zarow; Michael W Weiner; William G Ellis; Helena Chang Chui
Journal:  Brain Behav       Date:  2012-06-26       Impact factor: 2.708

10.  Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study.

Authors:  Weili Xu; Chengxuan Qiu; Margaret Gatz; Nancy L Pedersen; Boo Johansson; Laura Fratiglioni
Journal:  Diabetes       Date:  2008-10-24       Impact factor: 9.461

View more
  8 in total

1.  The Broad Range of Research in Alzheimer's Disease and Related Dementias.

Authors:  Steven T DeKosky; Ranjan Duara
Journal:  Neurotherapeutics       Date:  2022-05-13       Impact factor: 6.088

2.  A Randomized Controlled Trial Study of a Multimodal Intervention vs. Cognitive Training to Foster Cognitive and Affective Health in Older Adults.

Authors:  Maria Brasser; Sascha Frühholz; Andres R Schneeberger; Gian G Ruschetti; Rahel Schaerli; Michèle Häner; Barbara Studer-Luethi
Journal:  Front Psychol       Date:  2022-06-20

Review 3.  Blood-Brain Barrier Dysfunction and the Potential Mechanisms in Chronic Cerebral Hypoperfusion Induced Cognitive Impairment.

Authors:  WenQing Xu; Qingke Bai; Qiang Dong; Min Guo; Mei Cui
Journal:  Front Cell Neurosci       Date:  2022-06-16       Impact factor: 6.147

4.  Relationship Between Hypertension and Cognitive Function in an Elderly Population: A Population-Based Study in Rural Northern China.

Authors:  Jie Bao; Jie Liu; Zhiying Li; Zhen Zhang; Xiao Su; Jiayi Sun; Jun Tu; Jinghua Wang; Jidong Li; Yijun Song; Xianjia Ning
Journal:  Front Neurol       Date:  2022-05-16       Impact factor: 4.086

5.  Effect of Yisui Multipurpose Soup's Amelioration on D-Galactose-Induced Neuronal Cells.

Authors:  Junfeng Yan; Xia Zhang; Caixian Xiao; Junlu Yi; Qian Chen; Tingliang Gong; Xin Xie; Wenqiang Tao
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-15       Impact factor: 2.650

6.  Effect and Mechanism of Yisui Fuyongtang (YSFYT) Decoction on Cognitive Function and Synaptic Plasticity in Rats with Vascular Cognitive Impairment.

Authors:  Tingliang Gong; Zhaoliang Luo; Li Huang; Caixian Xiao; Junlu Yi; Junfeng Yan; Qian Chen; Weihong Li; Wenqiang Tao
Journal:  J Immunol Res       Date:  2022-07-08       Impact factor: 4.493

7.  Analysis of risk factors for the development of cognitive dysfunction in patients with cerebral small vessel disease and the construction of a predictive model.

Authors:  Le Zhang; Fulin Gao; Yamin Zhang; Pengjuan Hu; Yuping Yao; Qingzhen Zhang; Yan He; Qianlan Shang; Yi Zhang
Journal:  Front Neurol       Date:  2022-08-11       Impact factor: 4.086

Review 8.  Sirtuins and cognition: implications for learning and memory in neurological disorders.

Authors:  Eric Fagerli; Iris Escobar; Fernando J Ferrier; Charles W Jackson; Efrain J Perez-Lao; Miguel A Perez-Pinzon
Journal:  Front Physiol       Date:  2022-07-22       Impact factor: 4.755

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.